Document is current
Any future updates will be listed below
-
Authors
Knorr, Sine https://orcid.org/0000-0001-6552-5340
Skakkebæk, Anne
Just, Jesper
Johannsen, Emma B.
Trolle, Christian
Vang, Søren
Lohse, Zuzana
Bytoft, Birgitte
Damm, Peter
Højlund, Kurt
Jensen, Dorte M.
Gravholt, Claus H.
-
Funding
Funding for this research was provided by:
European Foundation for the Study of Diabetes
Danish Ministry of Science
Lundbeckfonden
Sundhedsvidenskabelige Fakultet, Aarhus Universitet
Danish Diabetes Academy
Beckett-Fonden
Novo Nordisk Fonden
Aase og Ejnar Danielsens Fond
Familien Hede Nielsens Fond
Sundhed, Region Midtjylland
- License Information
-
More Information
Article History
Received: 6 May 2022
Accepted: 3 August 2022
First Online: 23 September 2022
Declarations
:
: All participants provided informed consent. The study was approved by The Danish Data Protection Agency and approved by The Danish National Committee on Health Research Ethics in Central Region Denmark (M-20110239). All clinical investigations were conducted according to the Declaration of Helsinki. The research has been registered at (no. NCT01559181).
: Not applicable.
: CHG has given talks for Novo Nordisk (NN). PD is participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with NN; no personal honorarium is involved. None of the study funders had any role in study design, collection, analysis, interpretation, preparation of the manuscript, or in the decision to submit the article for publication.
